Patent Results

15 Results for: citation_id:14512185
Make Note

Egfr Mutations

Gene Expression Levels Of Egfr, Vegfr2, And Ercc1 Associated With Clinical Outcomes Of Chemotherapy

  • Published: May 3, 2012
  • Family: 2
  • Cited scholarly works: 13
  • Cited by: 0
  • Cites: 1
  • Additional Info: Cited Works Full text Published
  • Owner: University Of Southern California
  • Applicant: Lenz Heinz-josef, Univ Southern California

Egfr Mutations

Egfr Mutations

Method To Determine Responsiveness Of Cancer To Epidermal Growth Factor Receptor Targeting Treatments

  • Published: Aug 22, 2012
  • Family: 60
  • Cited scholarly works: 8
  • Cited by: 0
  • Cites: 1
  • Additional Info: Cited Works Published
  • Applicant: Gen Hospital Corp, Dana Farber Cancer Inst Inc

Egfr And Kras Mutations For Prediction Of Patient Response To Egfr Inhibitor Treatment

Egfr Mutations

  • Published: Mar 3, 2010
  • Family: 29
  • Cited scholarly works: 9
  • Cited by: 0
  • Cites: 0
  • Additional Info: Cited Works Published
  • Applicant: Genentech Inc

Method To Determine Responsiveness Of Cancer To Epidermal Growth Factor Receptor Targeting Treatments

  • Published: Jun 18, 2013
  • Family: 60
  • Cited scholarly works: 65
  • Cited by: 18
  • Cites: 10
  • Sequences: 762
  • Additional Info: Cited Works Full text Published Sequence
  • Owner: The General Hospital Corporation, Dana-farber Cancer Institute Inc
  • Applicant: Bell Daphne Winifred, Haber Daniel A, Janne Pasi Antero, Johnson Bruce E, Lynch Thomas J, Meyerson Matthew, Paez Juan Guillermo, Sellers William R, Settleman Jeffrey E, Sordella Raffaella, Gen Hospital Corp, Dana Farber Cancer Inst Inc

Egfr Mutations

Egfr And Kras Mutations

Add Note

Sorry, you can't add a note to multiple items. You can add a note to your search as a saved query. Did you want to save this search and add a note to it?

Cancel Save Query

Sign in to the Lens